Isoform 2 of nucleosome-remodeling factor subunit BPTF
I
L
D
L
S
S
M
A
P
Q
A
L
V
Q
F
W
POLQ DNA polymerase theta
T
R
I
F
G
D
A
L
A
S
I
K
Q
Q
A
Q
Isoform 1 of serine/arginine repetitive matrix protein
R
M
G
L
A
K
V
S
L
S
P
V
I
T
E
M
PLEC1 Isoform 6 of Plectin-1
G
G
I
V
T
L
S
Q
A
A
G
D
V
D
A
R
Isoform 6 of Nesprin-1
I
K
D
D
E
K
E
A
E
E
G
E
D
D
R
D
HNRPC protein
V
P
R
L
G
S
T
F
S
L
D
T
S
M
S
CBL E3 ubiquitin-protein ligase CBL
H
L
I
G
I
H
F
T
G
C
S
M
N
P
A
AQP6 Aquaporin-6
V
V
T
G
N
M
G
S
N
D
K
V
G
D
F
DSG1 Desmoglein-1
L
V
D
S
G
A
Q
V
S
V
V
H
P
N
L
ASPRV1 retroviral-like aspartic protease 1
L
G
H
P
D
T
L
N
Q
G
E
F
K
E
L
Calprotectin S100A9
G
R
C
I
Q
M
W
F
D
S
A
Q
G
N
FOLR3 folate receptor 3 precursor
M
S
F
L
W
P
V
H
A
E
P
N
P
D
Putative uncharacterized protein TTC39A
A
P
I
V
G
G
E
M
A
V
L
A
L
L
COL29A1 Isoform 1 of Collagen alpha-5(VI) chain
G
Q
G
S
N
G
Q
G
S
S
S
H
S
S
IRS4 Insulin receptor substrate 4
L
T
P
F
P
G
P
G
P
R
R
P
P
W
LMTK3 lemur tyrosine kinase 3
Y
R
S
G
G
G
F
S
S
G
S
A
G
I
KRT1 Keratin, type II cytoskeletal 1
S
L
I
N
N
H
I
P
C
L
I
S
G
Putative uncharacterized protein HMGN1
P
K
K
T
E
S
H
H
K
A
K
G
K
Histone H2A type 3
D
V
H
D
G
K
V
V
S
T
H
E
Q
KRT14 Keratin, type I cytoskeletal 14
A
S
G
Y
V
S
S
A
D
L
V
F
T
Isoform 2 of Cytokine receptor common subunit beta
L
D
G
K
V
I
S
F
E
G
C
A
V
Olfactory receptor 10S1
V
S
E
K
G
T
V
Q
Q
A
D
E
7 kDa protein
P
R
V
M
T
P
P
S
D
E
P
D
Protocadherin Fat 1
A
V
T
F
S
S
L
P
A
A
I
T
cDNA FLJ59480, highly similar to Smoothelin
G
P
Q
R
C
G
W
P
D
G
L
G
AP2 associated kinase 1
P
S
L
T
S
V
T
T
T
F
V
Olfactory receptor 51D1
S
K
G
K
I
Y
P
V
G
Y
52 kDa protein
P
G
H
C
E
D
V
L
V
L
Isoform 2 of Urea transporter 2
A
P
P
P
P
E
P
A
L
Homo sapiens selective LIM binding factor
Q
P
H
P
G
D
Q
S
E
HSPA1L putative uncharacterized protein
I
L
N
F
P
P
P
P
Isoform 2 of Caprin-2
I
V
E
S
R
P
V
P
XRN2 Isoform 1 of 5′-3′ exoribonuclease 2
I
I
A
I
F
G
P
G
Isoform 1 of multidrug resistance protein 3
M
K
A
A
P
G
V
E
Solute carrier family 12, member 6 isoform c
A
A
V
L
E
Y
L
Histone H2A type 2-B
Canonical HLA-E peptide ligands are reported to induce HLA-E surface expression, and noncanonical HLA-E peptide ligands are peptides that were identified within this study. The peptides selected for stabilization and cytotoxicity studies are highlighted in bold.
